BridgeMD
New treatment option for Anterior Shoulder Instability
Official title Sling vs. Dynamic Shoulder Stabilizer After Soft Tissue Shoulder Instability Surgery (SLIDY)
ClinicalTrials.gov ID: NCT07644624
What this study is testing
- What it's testing
- This randomized controlled trial seeks to address a significant clinical gap by evaluating the outcomes of two postoperative immobilization methods following arthroscopic soft tissue surgery for anterior shoulder instability: a standard static arm sling and a dynamic shoulder orthosis.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults aged ≥18 years undergoing arthroscopic soft-tissue stabilization for anterior shoulder instability (Bankart repair ± Hill-Sachs remplissage).
- Ability and willingness to comply with the study protocol and scheduled follow-ups.
- Provision of written informed consent.
You likely can't join if
- Significant glenoid bone loss requiring bony augmentation procedures (e.g., bone block procedures, Latarjet).
- Concomitant rotator cuff repair or fracture fixation.
- Contraindication to MRI (e.g., pacemaker, claustrophobia, incompatible implants).
- Cognitive impairment, language barriers, or logistical inability to attend follow-up visits.
- Previous ipsilateral shoulder surgery.
The study team makes the final eligibility decision.
Where it's taking place
- L'Hospitalet de Llobregat, Catalonia, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include L'Hospitalet de Llobregat, Catalonia, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.